Skip to main content
Utility menu
Donate
Join
Member Login
Search
Learn About Us
Learn About Us
Strategic Plan
Board of Directors
Committees
Awards
Staff
Contact
Careers
Support The Mission
Support The Mission
Become a Member
Explore Different Ways to Give
Create a Legacy
Join IASLC's Partners for Thoracic Cancer Care
Recognizing Our Donors
Celebrate IASLC's 50th Anniversary
Celebrate IASLC's 50th Anniversary
History
WCLC 2024 Highlights
Access Online Learning
Conferences & Education
Conferences & Education
Conferences
Webinars
Online Learning: Lung Cancer 360
Lung Cancer Considered Podcast
WCLC 2024
Science & Research
Science & Research
Journals
Journals
Journal of Thoracic Oncology
JTO Clinical and Research Reports (JTO CRR)
IASLC Reviewer Workshop
Scientific Projects
Scientific Projects
IASLC Staging Project: Lung Cancer, Thymic Tumors, and Mesothelioma
IASLC Global Survey on Biomarker Testing in Lung Cancer 2024 Update
IASLC Neoadjuvant Therapy in Lung Cancers Initiatives
IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer
ELIC
Past IASLC Scientific Projects
Research Grant Program
Research Grant Program
Research Grant Recipients
IASLC Academy
Publications, Resources & Guidelines
Membership
Membership
Become a Member
Renew Your Membership
Early-Career Opportunities
Partners Society Membership Offers
Patients & Caregivers
Patients & Caregivers
STARS Training
Lung Cancer Awareness Month
News
News
IASLC Lung Cancer News
WCLC 2024 News
Press Releases
Search
Fulltext search
Fulltext search
Search
Displaying 25 - 36 items out of 55 results
Resource
Patient Card - Precision Medicine
Resource
Patient Card - Clinical Trial
Resource
Patient Card - Advocacy
Resource
2022 Annual Report
Resource
What You Need to Know About Reading a Biomarker Test Report
Resource
Navigating Into the Deep of Molecular Profiling of NSCLC
Resource
The Management of Care for the Lung Cancer Patient Diagnosed During Pregnancy
Resource
Diagnosis and Management of Pleural Mesothelioma in the Era of Immunotherapy
Resource
Complete Response to Pembrolizumab as Monotherapy in a Patient with Baseline Stage IV NSCLC with Very High PD-L1 Expression
Resource
Diagnosis and Management of Multi-Synchronous Lung Adenocarcinoma
Resource
Histologic Transformation in Lung Cancer: The Crucial Role of Tissue Biopsy
Resource
Refractory Gastritis and Other Immune-Related Toxicities in a Patient with a Squamous NSLCLC
Pagination
First
First page
‹
Previous page
1
2
3
4
5
›
Next page
Last
Last page